MedTrace Logo

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

NCT05860920 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2025-05-13

No results posted yet for this study

Summary

The goal of this study is to measure the accuracy of a new measles rapid test when used in clinical health centres in several regions of Senegal. The rapid test will be used to test patients for measles who attend the participating health centres with signs and symptoms suggestive of measles infection. The rapid test can be used with a drop of blood from a finger, or oral fluid sampled with a swab rubbed over the gums. The rapid test will be compared to the standard methods of diagnosis in the laboratory using blood samples and oral or throat samples taken for surveillance purposes.

The main questions the study aims to answer are:

1. What is the accuracy of the rapid test when used with capillary blood (a drop of blood from the finger tip) in health centres by non-laboratory health professionals?
2. What is the accuracy of the rapid test when used with oral fluid by non-laboratory health professionals?

In addition to measuring the accuracy of the test, data will also be collected on whether the test is easy and practical to use and how best to record the results.

Conditions

Sponsors & Collaborators

  • Ministry of Health, Senegal

    collaborator OTHER_GOV

  • Epicentre

    collaborator OTHER

  • Institut Pasteur de Dakar

    lead OTHER

Principal Investigators

  • Cheikh Tidiane Diagne, PhD · Institut Pasteur de Dakar

  • Boly Diop · Ministry of Health, Senegal

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2026-02-28
Completion
2026-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05860920 on ClinicalTrials.gov